SSB
BIO icon

Sandy Spring Bank’s Bio-Rad Laboratories Class A BIO Stock Holding History

Sandy Spring Bank’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-150
Closed -$63.1K – 1171
2022
Q4 		$63.1K Hold
150
– – ﹤0.01% 491
2022
Q3 		$63K Hold
150
– – ﹤0.01% 474
2022
Q2 		$74K Hold
150
– – ﹤0.01% 453
2022
Q1 		$84K Hold
150
– – ﹤0.01% 445
2021
Q4 		$113K Hold
150
– – 0.01% 420
2021
Q3 		$112K Hold
150
– – 0.01% 403
2021
Q2 		$97K Buy
+150
New +$91.3K 0.01% 436

Other funds holding BIO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
VAM
Veritas Asset Management London, United Kingdom $5.9B AUM 3.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return